Skip to content

Aesculioside IIIb

C56H88O24 — CID 46888251

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC(2S,3S,4S,5R,6R)-6-[[(3S,4S,4aR,6aR,6bS,7R,8S,8aR,9R,10R,12aS,14aR,14bR)-7,8-dihydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(Z)-2-methylbut-2-enoyl]oxy-9-(2-methylpropanoyloxy)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2-carboxylic acid
SMILESC/C=C(/C)C(=O)O[C@H]1[C@H](OC(=O)C(C)C)[C@]2(CO)[C@H](O)[C@H](O)[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O[C@@H]7O[C@@H](CO)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2CC1(C)C
InChIInChI=1S/C56H88O24/c1-11-24(4)47(72)79-43-44(80-46(71)23(2)3)56(22-60)26(18-51(43,5)6)25-12-13-30-52(7)16-15-31(53(8,21-59)29(52)14-17-54(30,9)55(25,10)41(67)42(56)68)75-50-40(78-49-36(65)34(63)32(61)27(19-57)73-49)38(37(66)39(77-50)45(69)70)76-48-35(64)33(62)28(20-58)74-48/h11-12,23,26-44,48-50,57-68H,13-22H2,1-10H3,(H,69,70)/b24-11-/t26-,27+,28-,29+,30+,31-,32+,33-,34-,35+,36+,37-,38-,39-,40+,41-,42+,43-,44-,48-,49-,50+,52-,53+,54+,55-,56-/m0/s1
InChIKeyLIWXCZUYDRBOOQ-YOWFXSDUSA-N
MW1145.30 g/mol
LogP-1.08
Rot. Bonds15

About Aesculioside IIIb

Aesculioside IIIb (PubChem CID 46888251) has the molecular formula C56H88O24 and a molecular weight of 1145.30 g/mol. Its IUPAC name is (2S,3S,4S,5R,6R)-6-[[(3S,4S,4aR,6aR,6bS,7R,8S,8aR,9R,10R,12aS,14aR,14bR)-7,8-dihydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(Z)-2-methylbut-2-enoyl]oxy-9-(2-methylpropanoyloxy)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2-carboxylic acid.

Molecular Properties

Compound NameAesculioside IIIb
PubChem CID46888251
Molecular FormulaC56H88O24
Molecular Weight1145.30 g/mol
Exact Mass1144.57
IUPAC Name(2S,3S,4S,5R,6R)-6-[[(3S,4S,4aR,6aR,6bS,7R,8S,8aR,9R,10R,12aS,14aR,14bR)-7,8-dihydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(Z)-2-methylbut-2-enoyl]oxy-9-(2-methylpropanoyloxy)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2-carboxylic acid
SMILESC/C=C(/C)C(=O)O[C@H]1[C@H](OC(=O)C(C)C)[C@]2(CO)[C@H](O)[C@H](O)[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O[C@@H]7O[C@@H](CO)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2CC1(C)C
InChIInChI=1S/C56H88O24/c1-11-24(4)47(72)79-43-44(80-46(71)23(2)3)56(22-60)26(18-51(43,5)6)25-12-13-30-52(7)16-15-31(53(8,21-59)29(52)14-17-54(30,9)55(25,10)41(67)42(56)68)75-50-40(78-49-36(65)34(63)32(61)27(19-57)73-49)38(37(66)39(77-50)45(69)70)76-48-35(64)33(62)28(20-58)74-48/h11-12,23,26-44,48-50,57-68H,13-22H2,1-10H3,(H,69,70)/b24-11-/t26-,27+,28-,29+,30+,31-,32+,33-,34-,35+,36+,37-,38-,39-,40+,41-,42+,43-,44-,48-,49-,50+,52-,53+,54+,55-,56-/m0/s1
InChIKeyLIWXCZUYDRBOOQ-YOWFXSDUSA-N
XLogP-1.08
TPSA388.04 Ų
H-Bond Donors13
H-Bond Acceptors23
Rotatable Bonds15
Heavy Atoms80
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001145.30
LogP ≤ 5-1.08
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'saponine_derivative', 'substructure': 'N/A'}

Analyze Aesculioside IIIb with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Aesculioside IIIb?
The IUPAC name of Aesculioside IIIb (CID 46888251) is (2S,3S,4S,5R,6R)-6-[[(3S,4S,4aR,6aR,6bS,7R,8S,8aR,9R,10R,12aS,14aR,14bR)-7,8-dihydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(Z)-2-methylbut-2-enoyl]oxy-9-(2-methylpropanoyloxy)-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2-carboxylic acid.
What is the SMILES notation for Aesculioside IIIb?
The canonical SMILES for Aesculioside IIIb is C/C=C(/C)C(=O)O[C@H]1[C@H](OC(=O)C(C)C)[C@]2(CO)[C@H](O)[C@H](O)[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O[C@@H]7O[C@@H](CO)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2CC1(C)C.
What is the InChIKey of Aesculioside IIIb?
The InChIKey is LIWXCZUYDRBOOQ-YOWFXSDUSA-N. The full InChI is InChI=1S/C56H88O24/c1-11-24(4)47(72)79-43-44(80-46(71)23(2)3)56(22-60)26(18-51(43,5)6)25-12-13-30-52(7)16-15-31(53(8,21-59)29(52)14-17-54(30,9)55(25,10)41(67)42(56)68)75-50-40(78-49-36(65)34(63)32(61)27(19-57)73-49)38(37(66)39(77-50)45(69)70)76-48-35(64)33(62)28(20-58)74-48/h11-12,23,26-44,48-50,57-68H,13-22H2,1-10H3,(H,69,70)/b24-11-/t26-,27+,28-,29+,30+,31-,32+,33-,34-,35+,36+,37-,38-,39-,40+,41-,42+,43-,44-,48-,49-,50+,52-,53+,54+,55-,56-/m0/s1.
What are the key properties of Aesculioside IIIb?
Aesculioside IIIb has a molecular weight of 1145.30 g/mol, XLogP of -1.08, 15 rotatable bonds, 13 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for Aesculioside IIIb is sourced from PubChem (CID 46888251), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.